ANRO Alto Neuroscience, Inc. Common Stock

NYSE · Pharmaceuticals
$25,31
Prezzo · Mag 1, 2026
Fondamentali al Mar 16, 2026

ANRO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$25.30
Capitalizzazione di Mercato
$568M
P/E (TTM)
-8.1
EPS (TTM)
$-2.19
Ricavi (TTM)
Rendimento div.
ROE
-46.1%
D/E Debito/Patrimonio
0.1
Intervallo 52 sett.
$2 – $28

ANRO Grafico del prezzo delle azioni Daily OHLCV with technical indicators — pan, zoom, and customize your view

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto
EPS $-2.19
3-point trend, +77.5%
2023-12-31 2025-12-31
Flusso di cassa libero $-52M
2-point trend, -4.6%
2024-12-31 2025-12-31
Margini

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
ANRO
Mediana dei peer
P/E (TTM)
2-point trend, -380.4%
-8.1
42.1
P/B
2-point trend, +398.8%
3.8
2.5
EV / EBITDA
2-point trend, -1056.8%
-6.2
Price / FCF (Prezzo / FCF)
2-point trend, -375.7%
-11.0

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
ANRO
Mediana dei peer
ROA
2-point trend, +24.9%
-34.9%
-22.8%
ROE
2-point trend, -18.7%
-46.1%
-48.2%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
ANRO
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
2-point trend, +63.8%
0.1
47.0
Current Ratio (Rapporto corrente)
2-point trend, -7.3%
15.7
4.2
Quick Ratio
2-point trend, -7.3%
15.6

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
ANRO
Mediana dei peer

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
ANRO
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
3-point trend, +77.5%
$-2.19

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
ANRO
Mediana dei peer

ANRO Consenso Analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 16 analisti
  • Acquisto forte 7 43,8%
  • Compra 7 43,8%
  • Mantieni 2 12,5%
  • Vendi 0 0,0%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

9 analisti · 2026-05-01
Target mediano $35.00 +38,3%
Target medio $35.27 +39,4%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.04%
Periodo EPS Actual EPS Stimato Sorpresa
31 Dicembre 2025 $-0.58 $-0.54 -0.04%
30 Settembre 2025 $-0.52 $-0.68 0.16%
30 Giugno 2025 $-0.65 $-0.63 -0.02%
31 Marzo 2025 $-0.56 $-0.62 0.06%

Confronto tra pari Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
ANRO $568M -8.1 -46.1%
PCRX $1.06B 161.8 3.6% 0.97% 0.97%
AMPH $1.22B 13.2 -1.7% 13.6% 12.7% 49.5%
LBRX $563M -7.1 -25.5%
PHAT $1.18B -5.5 216.9% -126.4% 52.4% 87.1%
RLMD $354M -3.3 93.7% -112.0%
SGP 50.0%
BIOA $495M -5.9 -896.1% -28.4%
LXRX $421M -8.2 60.2% -101.1% -39.7%
ETON $457M 104.9% -5.8% -18.4% 53.5%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 13
Dati annuali Conto Economico per ANRO
Metrica Tendenza 202520242023
R&D Expense 3-point trend, +50.6% $46M $47M $30M
SG&A Expense 3-point trend, +175.9% $21M $22M $8M
Operating Expenses 3-point trend, +75.5% $66M $69M $38M
Operating Income 3-point trend, -75.5% $-66M $-69M $-38M
Interest Income 3-point trend, +181.1% $7M $9M $2M
Other Non-op 3-point trend, +107.8% $3M $7M $2M
Income Tax Flat — no change across 3 periods $0 $0 $0
Net Income 3-point trend, -74.2% $-63M $-61M $-36M
EPS (Basic) 3-point trend, +77.5% $-2.19 $-2.50 $-9.73
EPS (Diluted) 3-point trend, +77.5% $-2.19 $-2.50 $-9.73
Shares (Basic) 3-point trend, +673.3% 28,852,000 24,602,000 3,731,000
Shares (Diluted) 3-point trend, +673.3% 28,852,000 24,602,000 3,731,000
EBITDA 2-point trend, +2.6% $-66M $-68M ·
Stato Patrimoniale 20
Dati annuali Stato Patrimoniale per ANRO
Metrica Tendenza 202520242023
Cash & Equivalents 3-point trend, +113.8% $176M $168M $83M
Prepaid Expense 3-point trend, -56.6% $1M $1M $3M
Other Current Assets 2-point trend, -73.2% · $30.0K $112.0K
Current Assets 3-point trend, +108.1% $178M $169M $85M
PP&E (Net) 3-point trend, +69.3% $2M $3M $1M
Accum. Depreciation 3-point trend, +123.1% $2M $1M $684.0K
Total Assets 3-point trend, +113.2% $185M $178M $87M
Accounts Payable 3-point trend, +74.9% $2M $2M $1M
Accrued Liabilities 3-point trend, +95.4% $9M $8M $5M
Current Liabilities 3-point trend, +101.9% $11M $10M $6M
Capital Leases 3-point trend, +3823000.00 $4M $5M $0
Total Liabilities 3-point trend, +99.4% $34M $26M $17M
Long-term Debt 3-point trend, +69.9% $17M $10M $10M
Total Debt 2-point trend, +63.4% $17M $10M ·
Paid-in Capital 3-point trend, +6466.5% $353M $290M $5M
Retained Earnings 3-point trend, -162.0% $-202M $-138M $-77M
AOCI 3-point trend, +127.8% $22.0K $-101.0K $-79.0K
Stockholders' Equity 3-point trend, +310.9% $151M $151M $-72M
Liabilities + Equity 3-point trend, +113.2% $185M $178M $87M
Shares Outstanding 3-point trend, +733.1% 31,924,000 26,987,000 3,832,000
Flusso di cassa 10
Dati annuali Flusso di cassa per ANRO
Metrica Tendenza 202520242023
D&A 2-point trend, +34.6% · $502.0K $373.0K
Stock-based Comp 3-point trend, +180.5% $8M $8M $3M
Other Non-cash · $6M ·
Operating Cash Flow 3-point trend, -54.8% $-52M $-47M $-33M
CapEx 3-point trend, -94.9% $24.0K $2M $470.0K
Investing Cash Flow 3-point trend, +94.9% $-24.0K $-2M $-470.0K
Net Debt Issued $-10M · ·
Financing Cash Flow 3-point trend, -11.8% $60M $136M $68M
Net Change in Cash 3-point trend, -75.9% $8M $86M $34M
Free Cash Flow 2-point trend, -4.6% $-52M $-49M ·
Redditività 2
Dati annuali Redditività per ANRO
Metrica Tendenza 202520242023
ROA 2-point trend, +24.9% -34.9% -46.5% ·
ROE 2-point trend, -18.7% -46.1% -38.8% ·
Liquidità e Solvibilità 4
Dati annuali Liquidità e Solvibilità per ANRO
Metrica Tendenza 202520242023
Current Ratio 2-point trend, -7.3% 15.7 16.9 ·
Quick Ratio 2-point trend, -7.3% 15.6 16.8 ·
Debt / Equity 2-point trend, +63.8% 0.1 0.1 ·
LT Debt / Equity 2-point trend, +58.1% 0.1 0.1 ·
Per Azione 4
Dati annuali Per Azione per ANRO
Metrica Tendenza 202520242023
Book Value / Share 2-point trend, -15.6% $4.73 $5.61 ·
Cash Flow / Share 2-point trend, +6.9% $-1.79 $-1.93 ·
Cash / Share 2-point trend, -11.3% $5.53 $6.23 ·
EPS (TTM) 3-point trend, +77.5% $-2.19 $-2.50 $-9.73
Valutazione (TTM) 11
Dati annuali Valutazione (TTM) per ANRO
Metrica Tendenza 202520242023
Net Income TTM 3-point trend, -74.2% $-63M $-61M $-36M
Market Cap 2-point trend, +397.8% $568M $114M ·
Enterprise Value 2-point trend, +1032.3% $409M $-44M ·
P/E 2-point trend, -380.4% -8.1 -1.7 ·
P/B 2-point trend, +398.8% 3.8 0.8 ·
P / Tangible Book 2-point trend, +398.8% 3.8 0.8 ·
P / Cash Flow 2-point trend, -356.0% -11.0 -2.4 ·
P / FCF 2-point trend, -375.7% -11.0 -2.3 ·
EV / EBITDA 2-point trend, -1056.8% -6.2 0.6 ·
EV / FCF 2-point trend, -991.0% -7.9 0.9 ·
Earnings Yield 2-point trend, +79.2% -12.3% -59.1% ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-31
Utile netto $-63M$-61M$-36M
EPS Diluito $-2.19$-2.50$-9.73
Stato Patrimoniale
2025-12-312024-12-312023-12-31
Debito / Patrimonio Netto 0.10.1
Rapporto corrente 15.716.9
Quick Ratio 15.616.8
Flusso di cassa
2025-12-312024-12-312023-12-31
Flusso di cassa libero $-52M$-49M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.